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Although sarcopenic obesity (SO) poses a major public health concern, a robust approach for 54 
the optimization of body composition and strength/function in SO has not yet been 55 
established. The purpose of this systematic review was to assess the effectiveness of 56 
nutritional (focusing on energy and protein modulation) and exercise interventions, either 57 
individually or combined, on body composition and strength/function in older adults with SO. 58 
MEDLINE, the Cochrane Central Register of Controlled Trials, CINAHL and SPORTDiscus 59 
were searched. Main inclusion criteria comprised sarcopenia as defined by the European 60 
Working Group on Sarcopenia in Older People (EWGSOP) and obesity defined as % body 61 
fat ≥ 40 % (women) and ≥ 28 % (men). Randomized controlled trials (RCTs), randomized 62 
controlled crossover trials and controlled clinical trials with older adults (mean age ≥65 63 
years) following a nutritional regimen and/or an exercise training program were considered. 64 
Out of 109 full text articles identified, only two RCTs (61 participants) met the inclusion 65 
criteria. One study was a nutritional intervention adding 15 g protein·day-1 (via cheese 66 
consumption) to the participants’ habitual diet. The second study was a high-speed circuit 67 
resistance training intervention. Body composition did not change significantly in either of 68 
the studies. However, the exercise intervention improved significantly muscle strength and 69 
physical function. Although this review was limited by the small number of eligible studies, it 70 
provides evidence for the potential benefits of exercise and highlights the necessity for future 71 
research to develop effective interventions including dietary and exercise regimens to combat 72 
sarcopenic obesity.  73 
 74 
Keywords: Aged; sarcopenia; obesity; dietary proteins; exercise; systematic review75 
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1. Introduction  76 
 77 
Sarcopenia is defined by the European Working Group on Sarcopenia in Older People 78 
(EWGSOP) as the age-related decline of muscle mass and strength or function [1]. Low 79 
strength and muscle mass are associated with poor functional status, physical impairments, 80 
frailty, increased risk of falls, loss of independence and higher mortality risk [1][2]. It has 81 
been suggested that in older people, strength is a stronger predictor of functional impairment 82 
and mortality rates than absolute changes in muscle mass or lean mass alone [3-6]. Secondary 83 
to functional impairments, muscle atrophy may also contribute to insulin resistance as muscle 84 
tissue plays the main role in glucose uptake and utilization [7]. According to a recent 85 
systematic review, the prevalence of sarcopenia may vary from 1 % to 29 % in community-86 
dwellers and 14-33 % in long-term care populations [8].  87 
 88 
Another condition that can promote poor health is obesity, which is defined as ‘abnormal or 89 
excess body fat accumulation’ [9], and is a growing concern due to its progressively rising 90 
prevalence rates in older populations [10]. In 2010, 35 % and 28 % of the adults 65 years of 91 
age and older were reported to be obese in the US and the UK, respectively [11][12]. Similar 92 
to sarcopenia, obesity can increase the risk of falls and mobility limitations in older age 93 
[13][14], and when used in conjunction with indices of body composition and fat distribution 94 
(waist circumference or waist to hip ratio) it may be associated with adverse health effects, 95 
such as cardiovascular disease, metabolic syndrome, diabetes mellitus and several cancers 96 
[15]. Furthermore, adipose tissue can infiltrate the muscle tissue [16] and mediate an 97 
inflammatory response [17], which can result in muscle atrophy, mobility losses and lower 98 




The relationship between sarcopenia and obesity is complex, with the development/ 101 
progression of one condition being closely connected to the other (Figure 1). The condition 102 
where sarcopenia and obesity occur together has been termed sarcopenic obesity (SO) [20]. It 103 
has been suggested that SO can predispose older individuals to more physical disabilities, gait 104 
and balance abnormalities, and an increased risk of falls compared with either of the two 105 
conditions alone [21]. Individuals with SO are exposed to ~2.5 times higher risk of reporting 106 
Instrumental Activities of Daily Living (IADL) disabilities compared with adults without 107 
obesity but with sarcopenia, or adults with obesity but without sarcopenia [22]. This negative 108 
synergistic effect of sarcopenia and obesity is in accordance with the findings from the 109 
EPIDOS (EPIDemiologie de l’OSteoporose) study, which reported that among a cohort of 110 
1,308 women divided in four groups: 1) without sarcopenia or obesity 2) with obesity but not 111 
sarcopenia 3) with sarcopenia but not obesity and 4) with SO, the latter was the poorest in 112 
terms of performing physical activities that required strength [23]. According to a meta-113 
analysis of 12 prospective cohort studies with a total number of 35,287 participants, the 114 
adults with SO had a 24 % higher risk of all-cause mortality compared with their healthy 115 
counterparts [24].   116 
 117 
Figure 1 Relationship between sarcopenia and obesity and associated outcomes   118 
 119 
Although SO has gained significant attention from the scientific community in recent years, 120 
and a plethora of existing definitions and cut-offs for sarcopenia and obesity exist, there is no 121 
universally accepted definition for SO [1][25][26].  Depending on the definition criteria and 122 
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cut-offs used the prevalence rates of SO can vary up to 26-fold, which makes detection and 123 
management of the condition challenging for healthcare practitioners [27]. Moreover, there 124 
are operational challenges around the management of SO. While exercise training can be 125 
beneficial for both obesity and sarcopenia, the dietary management of obesity may require 126 
energy restriction, whilst management of sarcopenia requires an increased intake of 127 
macronutrients, especially protein [28].  128 
 129 
This has resulted in a growing body of evidence highlighting potentially beneficial nutritional 130 
and exercise strategies, aiming to reverse or attenuate the negative effects of ageing on body 131 
composition and physical function [29-31]. Particular focus has been placed on protein 132 
intake, energy modulation and resistance exercise [32][33]. With regard to protein intake, 133 
there seems to be a consensus for the benefits of increased protein intake, ranging from 1.0 g· 134 
kg bw-1· day-1 to 1.5 g· kg bw-1· day-1, with the higher values appropriate for those older 135 
adults with chronic conditions, sarcopenia and malnutrition, or when combined with 136 
resistance exercise [28][34][35]. 137 
 138 
 However, there are relatively few intervention studies utilizing exercise training and/or 139 
nutritional regimens for older adults with SO [26][36]. It appears that most intervention trials 140 
have aimed to attenuate muscle loss at an early stage rather than try to ‘reverse’ an 141 
established condition related to advanced ageing such as sarcopenia or SO, which would be 142 
far more challenging [37]. Furthermore, to the best of our knowledge, there has been no 143 
systematic review to date assessing the effectiveness of nutritional and exercise strategies, 144 
alone or combined, to improve body composition and strength/function indices in older 145 
individuals with SO. Therefore, the purpose of this systematic review was to assess the 146 
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evidence for the use of diets modulating energy and protein (or amino acids) content, exercise 147 
training regimens, or diet and exercise training combined, in older adults with SO.   148 
 149 
The focus of this systematic review was to determine the effectiveness of protein or energy-150 
modulating regimens, with or without exercise training on body composition and function in 151 
adults, 65 years of age and older with SO. In particular, our aims were to 1) determine 152 
changes in absolute muscle mass, total appendicular skeletal muscle (TASM), skeletal muscle 153 
index (SMI), fat mass, % body fat, body weight and body mass index (BMI), 2) assess 154 
changes in muscle strength and/or physical function (including muscle strength, power, gait 155 
speed and balance and 3) evaluate the effect of these interventions on quality of life, 156 
metabolic profile, activities of daily living, adverse effects of supplementation or food 157 
choices, compliance rates and changes in habitual dietary intake during or after the 158 
interventions.   159 
 160 
2. Approach 161 
 162 
This systematic review was performed according to the Preferred Reporting for Systematic 163 
Reviews and Meta-analyses (PRISMA) guidelines [38]. The protocol was registered with the 164 
International prospective register of systematic reviews (PROSPERO registration number: 165 
CRD42015017311).  166 
 167 




The Cochrane Central Register of Controlled Trials, MEDLINE (via EBSCOhost Research 170 
Databases), CINAHL  and SPORTDiscus  were searched up to and including May 2016. The 171 
last search was conducted on 22 May 2016. No limits were applied for date of publication. 172 
Combinations of key terms with Medical Subject Headings (MeSH) and Boolean operators 173 
were used. The main keywords and terms used were: Age*/ Adult*/ Old*/ Elderly/ Senior, 174 
Sarcopeni*/ Lean/ Frail/ Atrophy/ Weakness, Obes*/ Overweight/ Body Mass Index, 175 
Exercise/ Training/ Strength/ Muscle/ Mass/ Hypertrophy/ Size/ Body Composition, Diet/ 176 
Supplements/ Protein/ Amino Acids/ Energy, Life Quality/ Intervention. The search limiters 177 
were English language and studies with human participants [the complete search strategy is 178 
presented in supplementary file 2]. 179 
 180 
2.2. Inclusion Criteria  181 
 182 
We included randomized control trials (RCTs), randomized control crossover trials and 183 
controlled clinical trials using prospective nutritional and/or exercise interventions to 184 
attenuate/ reverse the loss of muscle mass, reduce adipose tissue and optimize muscle 185 
strength or function.  Given that there are no universally adopted definition criteria for SO, 186 
some authors may have used different terms to define the participants, e.g. ‘weak and 187 
overweight’ or ‘obese frail’ etc. Such studies were included only if the participants had a 188 
sarcopenic phenotype based on the definition criteria and cut-off scores recommended by the 189 
EWGSOP [1]. Therefore, studies were included only if they presented data for a) body 190 
composition (data on absolute muscle mass, appendicular muscle mass, Total Appendicular 191 
Skeletal Muscle (TASM) or Skeletal Muscle Index (SMI) assessed by Dual-energy X-ray 192 
Absorptiometry (DXA), Bioelectrical Impedance Analysis (BIA), Computerised Tomography 193 
(CT) or Magnetic Resonance Imaging (MRI) and b) muscular strength and/ or physical 194 
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function identified by one of the following tests: handgrip strength, knee flexion/extension, 195 
peak expiratory flow, gait speed, the Short Physical Performance Battery test (SPPB), the 196 
timed up-and-go test or the stair climb power test . The mean age cut-off for inclusion was ≥ 197 
65 years based on how ‘old age’ is defined in the joint recommendations from the American 198 
College of Sports Medicine (ACSM) and the American Heart Association (AHA) [39]. The 199 
inclusion criterion for obesity was defined as mean percentage body fat (% BF) ≥ 28 % in 200 
men and ≥ 40 % in women [22] or in the absence of % BF data, a BMI ≥ 27 kg·m-2. For any 201 
given BMI, a person with sarcopenia will have by definition more body fat compared with 202 
their counterparts without sarcopenia, therefore, adults with sarcopenia can present high-203 
adiposity at BMIs substantially lower than 30 kg·m-2 [40]. Moreover, it is not uncommon for 204 
studies to recruit participants who would be classified as overweight or obese based on a BMI 205 
cut-off ranging from 25 to 28 kg·m-2 when the focus is on sarcopenic obesity and/or when 206 
participants come from a non-Caucasian ethnic group [25][26]. Studies that presented neither 207 
the % BF nor BMI were included only if these indices could be derived from the weight, 208 
height and body fat mass values, or if the authors of the study when contacted provided the 209 
essential information. 210 
 211 
 Nutritional interventions aiming to promote muscle hypertrophy by macronutrient profile 212 
modification or weight loss via energy restriction were of primary interest. Studies providing 213 
extra macronutrients (especially proteins or amino acids and their metabolites) either in the 214 
form of whole foods or dietary supplements administered through the oral route only were 215 
considered. Exercise regimens including resistance, balance, aerobic and mixed exercise 216 
protocols influencing lean mass, fat mass, muscle hypertrophy, strength, power, speed and/ or 217 




2.3. Exclusion Criteria  220 
 221 
Studies were excluded if the protocol involved administration of any kind of prescription 222 
only/pharmaceutical agents, or any type of supplementation administered via a route other 223 
than oral. Studies including participants with cachexia or with serious mental and cognitive 224 
conditions prohibiting adherence to a structured exercise/ nutrition regimen, such as 225 
Alzheimer’s or dementia, were excluded.  226 
 227 
2.4. Study Selection 228 
 229 
The titles and abstracts were screened for eligibility (CT), and the full text copies of 230 
potentially eligible articles were obtained for further inspection. The full-text articles were 231 
independently assessed for eligibility by two reviewers (CT and JJ). The reference lists of 232 
eligible articles and review papers as well as journals specializing in older age were hand 233 
searched for potential articles. Any disagreement between the two reviewers was resolved by 234 
a third reviewer (CAG).    235 
 236 
2.5. Data Extraction 237 
Data were extracted from each eligible article by two reviewers (CT and CAG). Any 238 
disagreements between the two reviewers were resolved by discussion until consensus was 239 
reached. Demographic (age, sex, ethnicity/host country and habitation), methodological 240 
(study design, sample sizes, duration, nutritional/dietary and/or exercise intervention plan, 241 
supplement type, dosing/frequency of administration, exercise training 242 
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type/frequency/volume, assessment method, blinding) and outcome data (changes within and 243 
between groups, significance, dropout rates, compliance, adverse effects) were compiled in a 244 
standardized Excel spreadsheet.  245 
 246 
2.6. Quality Assessment 247 
 248 
The quality of the studies was assessed by two independent reviewers using a modified 249 
version of the Downs and Black rating scale [41][42]. The Downs and Black scale is one of 250 
the most credible instruments for the quality assessment of randomized [43] and non-251 
randomized intervention trials [44]. Modified scoring for Question 27 was performed as 252 
detailed by Eng et al. [42]: the original scale had a maximum score of 32 but in this review 253 
Question 27 was modified to score either 0 or 1 point instead of the original 0-5 points. 254 
Therefore, the maximum total score for the five sections of the scale (reporting, external 255 
validity, internal validity/bias, internal validity/confounding, power) was 28.  256 
 257 
2.7. Principal Summary Measures  258 
 259 
The primary outcome measures were 1) differences in mean of skeletal muscle mass (either 260 
absolute, relative or appendicular) and body fat or BMI, and 2) differences in mean of muscle 261 
strength and physical function/performance  262 
 263 




3.1. Description of studies 266 
 267 
Our search strategy resulted in 1,440 potential articles. After the exclusion of 1,331 articles 268 
based on titles and abstracts, 109 full-text articles reporting 109 studies were retrieved and 269 
assessed for eligibility. The detailed flow chart of the selection process is presented in Figure 270 
2. The authors of two potentially eligible studies [45][46] were contacted for further 271 
information, but retrieval of all the essential body composition data was not possible for 272 
reasons unrelated to this review, therefore, the articles were excluded.  A total of n=2 studies 273 
[47][48] including n= 61 participants met the inclusion criteria and were included in the 274 
review. Study A[47] was a nutritional intervention and study B[48] an exercise training 275 
intervention; neither of the studies combined exercise with diet.  276 
 277 
Figure 2. Information flow through the phases of the systematic review according to 278 
PRISMA guidelines. 279 
 280 
3.2. Quality Assessment  281 
 282 
The two studies were randomized control trials of moderate methodological quality based on 283 
the modified Downs and Black rating scale [41][42]. The total score for each study was 18 284 
out of 28. The summary key information of the methodological strengths and limitations is 285 
presented in table 1 (supplementary file 1 presents the complete breakdown of the scoring in 286 
the different subsections of the scale). Both studies performed power calculations to 287 
determine the population sample size prior to recruitment, however, study B[48] was 288 
underpowered; target was n=21 per group, but the final analysis was conducted with n=9 and 289 
n=8 for the control and intervention group, respectively. In study A[47] only the testers were 290 
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blinded but not the participants. In study B[48] the two groups were exercising at different 291 
times, therefore, participants were partially blinded. Study A[47] reported and tested for a 292 
range of potential confounders, but failed to report essential information regarding the 293 
participants’ dietary intake at baseline and follow-up. The results in Study A were based on 294 
an intention-to-treat analysis, whereas in Study B the analysis conducted was per-protocol.  295 
 296 
Table 1. Summary key points of the included study designs. 297 
 298 
3.3. Participant Characteristics  299 
 300 
Participants in study A[47] were physically-independent individuals living in Mexico. Their 301 
mean± SD age and TASM were 76± 5.4 years and 15.5± 2.9 kg, respectively. The mean % 302 
BF of men and women was 33.3± 6.2 % and 47.8± 6.6 %, respectively. At baseline two men 303 
had a % BF < 28 % and three women < 40 %. All participants in study B[48] were 304 
independent-living community dwellers from South Miami (USA). The mean ± SD age and 305 
BMI of participants was 71.3 ± 7.8 years and 32.6 ± 4.7 kg · m-2, respectively and their mean 306 
SMI 6.6 ± 1.0 kg · m-2.   307 
 308 
3.4. Study Design    309 
 310 
The aim of study A[47] was to assess whether the addition of a protein rich food to the 311 
habitual diet could increase TASM and strength in older individuals with sarcopenia. The 312 
study was a 3-month RCT with a control (habitual diet; HD) and an intervention group 313 
(habitual diet + 210 g ricotta cheese per day; RCH+HD). The cheese provided 15.7 g extra 314 
protein (including 8.6 g of essential amino acids), 10.4 g carbohydrate, 18.4 g fat and a total 315 
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of 267 kcal per day.  Cheese was divided into three 70 g portions and participants were 316 
instructed to consume each portion along with their usual breakfast, lunch and dinner. Dual-317 
energy x-ray absorptiometry was used to measure TASM and body composition changes.  318 
  319 
Study B[48] was a 15-week single blind RCT, which aimed to assess the effectiveness of a 320 
novel exercise regime based on a high speed circuit (HSC) resistance training program 321 
(intervention) on body composition, muscular performance and IADL compared with a 322 
conventional strength hypertrophy (SH) regime (control group) in community-dwellers with 323 
SO. Body composition was assessed by single frequency BIA. Both groups performed 324 
exercises at 11 pneumatic gym machines twice per week. The SH protocol involved three sets 325 
of 10-12 repetitions at 70 % of 1RM with a 1-2 min recovery break between sets. Participants 326 
were instructed to keep a similar speed of contraction  for both the concentric and eccentric 327 
phase (2 seconds per phase). The HSC group performed 10-12 repetitions at the same 11 328 
exercises, but in a circuit pattern (i.e. moving from one exercise to the other) with no break in 329 
between exercises, unless one full circuit was complete. Three full circuits were performed in 330 
total. The resistance load was selected based on maximum power output for each machine. 331 
The concentric phase was performed as fast as possible while the eccentric in 2 seconds. No 332 
dietary or nutritional element was introduced in the study, and neither dietary patterns nor 333 
intakes were reported.   334 
 335 
3.5. Outcomes  336 
 337 




No significant changes were seen in body composition, in either experimental or control 340 
groups. In study A[47] the addition of ricotta cheese resulted in no significant changes in lean 341 
mass, TASM or body fat in the intervention or control group (Table 2). Secondary analysis 342 
by sex showed that although men (n=8) in the intervention group experienced an increase in 343 
TASM by 490 g, this was not significantly different either from baseline or when compared 344 
against the control group (p=0.42), which gained a non-significant 220 g of TASM.  345 
Similarly, in study B[42] no statistically significant differences were detected in any of the 346 
body composition indices, regardless of the exercise regimen (Table 2). Skeletal muscle 347 
index (SMI) increased non-significantly in both groups (from 6.5 ± 0.66 kg·m-2 to 6.6 ± 0.59 348 
kg·m-2 in HSC and from 6.7 ± 0.45 kg·m-2 to 6.8 ± 0.42 kg·m-2 in SH).  349 
 350 
Table 2. Summary of the included studies 351 
3.5.2 Strength and/ or function 352 
 353 
In study A[47], the group receiving the extra protein noted a non-significant trend towards an 354 
increase in strength (+ 0.9 % relative increase). Although the control group experienced a 355 
drop in strength (-3.5 %), the difference between the two groups did not achieve statistical 356 
significance (p=0.06).  357 
 358 
Study B[48] reported significant improvements in several aspects of strength and function in 359 
both exercise groups (Table 2). In particular, the strength-hypertrophy (SH) control group 360 
experienced significant improvements in leg press 1RM by 22 % (p<0.01), chest press 1RM 361 
by 16 % (p=0.03), leg press peak power by 19 % (p=0.03) and chest press peak power by 362 
15% (p<0.01) whereas a non-significant increase of 12% was detected in hand grip strength 363 
(from 17.3 ± 2.7 kg to 19.4 ± 4.6 kg; p>0.05). The HSC group had a significant improvement 364 
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in chest press 1RM by 21 % (p<0.01), leg press peak power by 41% (p<0.01) chest press 365 
peak power by 24 % (p<0.01) but hand grip strength did not change significantly (increased 366 
by 10 %, from 17.7 ± 7.8 kg to 19.4 ± 6.6 kg; p>0.5). Between group differences were 367 
detected only for leg press peak power, with the HSC group performing better than the 368 
control by 158 W [95 % CI (2, 315), p=0.005].    369 
 370 
The Short Physical Performance Battery (SPPB) test improved significantly over time only 371 
within the HSC group from 8.0 ± 1.5 to 9.6 ±1.2 (p=0.02).  Between group differences 372 
favored the HSC group [mean difference 1.1 (95 % CI (-0.1, 2.4), p=0.08], although this was 373 
not statistically significant.  374 
 375 
3.5.3 Secondary Outcomes  376 
 377 
Consumption of ricotta cheese in study A[47], resulted in significantly lower fasting insulin 378 
levels in men (p=0.05) but not in women. There were no other significant changes in hepatic 379 
markers (Serum Glutamic Oxaloacetic Transaminase (SGOT), Serum Glutamic-Pyruvic 380 
Transaminase (SGPT) and Alkaline Phosphatase), kidney function (blood urea, uric acid, 381 
creatinine and Glomerular Filtration Rate (GFR)), anabolism (Insulin-like Growth Factor-1 382 
(IGF-1)) or insulin resistance. No cases of microalbuminuria were present in the RCH+HD 383 
group after the intervention period. In the intervention group, 25 % of women reported early 384 
satiety after the consumption of ricotta cheese, however, dietary intakes were not reported. 385 
Eight participants from the intervention group dropped out; five were due to personal health 386 
issues, two could not eat the entire portion of ricotta cheese, and one had to relocate. In the 387 
control group three people dropped out (two for personal reasons and one for modifying the 388 
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habitual diet). However, all participants were measured pre- and post-intervention according 389 
to an intention-to-treat analysis.      390 
 391 
The exercise intervention in study B[48] resulted in acute joint pain only in the SH group. In 392 
addition, the HSC group reported significantly lower rates of perceived exertion (RPE) with a 393 
mean difference of -1.5 (95 % CI -2.0,-0.12, p=0.04). Adherence rates were similar in the two 394 
groups; 81 % in HSC and 85 % in SH. Regarding the Instrumental Activities of Daily Living 395 
(IADLs) there were significant improvements within both groups (pre vs post); namely, time 396 
needed for jacket on and off (from 11.5 ± 3.5 s to 10.2 ± 2.0 s; p=0.04), scarf pick-up (5.2 ± 397 
1.1 s to 4.7 ± 0.91 s; p<0.01 and pan carry (4.9 ± 0.61 s to 3.9± 0.77 s; p<0.01) improved 398 
significantly within the control group, while the HSC group experienced significant 399 
improvements in time for sit-to-stand (from 16.1 ± 5.7 s to 13.4 ± 3.9 s; p=0.02) and pan 400 
carry (5.4 ± 1.3 s to 4.5 ± 1.2 s; p<0.01). No differences were observed between the two 401 
groups in the aforementioned IADLs.     402 
 403 
In summary, neither of the studies had a significant effect on body composition. The 404 
introduction of ricotta cheese in the habitual diet of participants in study A[47] aimed to 405 
increase their protein intake but it was not reported whether or not this was achieved, and if 406 
so to what extent. In the same study, there was a trend for an increase in strength in the 407 
intervention group, but this was not significant. The only significant improvement reported 408 
was the fasting insulin levels, but that was reported only in men in the intervention group. 409 
Despite the lack of body composition changes, in study B[48], the high speed circuit 410 
resistance training and strength hypertrophy resistance training protocols significantly 411 
improved strength, power and function indices. Finally, due to the limited data extracted and 412 
19 
 
diversity of methodologies, statistical pooling was not feasible and therefore, a narrative 413 
analysis was conducted.   414 
4. Discussion  415 
 416 
The aim of this systematic review was to assess the effectiveness of nutritional and/or 417 
exercise interventions on body composition and strength or function in older adults with 418 
obesity and sarcopenia. Although only two studies were identified, the lack of intervention 419 
trials clearly highlights the need for more research in this area, especially trials combining 420 
exercise with nutritional approaches targeting this population group. With regard to the main 421 
outcomes, neither an increase in protein intake by 15g · day-1 nor a 15-week resistance 422 
exercise protocol produced significant improvements in body composition indices. However, 423 
the exercise intervention (both the control group following a strength-hypertrophy resistance 424 
exercise protocol and the intervention group utilizing a high-speed power-orientated circuit 425 
resistance training) reported significant improvements in both strength and function.  426 
 427 
4.1 Effects of protein intake on body composition and function in sarcopenic obesity 428 
 429 
Study A[47] attempted to utilize the effects of protein on increased skeletal muscle mass 430 
accretion rates. Although the authors acknowledged that the suggested recommendations for 431 
protein intake in older individuals with sarcopenia are 1.2- 1.5 g ·kg bw-1 ·day-1 [47], they did 432 
not report the participants’ daily protein intake, therefore, it was not corroborated whether 433 
such intakes were achieved. It has been suggested that maximal muscle protein synthesis 434 
(MPS) rates in older adults can be achieved using ~35- 40 g protein · meal-1 [49-51] or 0.4 g 435 
protein · kg bw-1 · meal-1 [51]. A valid question would be whether a daily addition of 210 g 436 
ricotta cheese (delivering 15.7 g protein [47]) to the habitual diet could practically augment 437 
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muscle mass in older adults with sarcopenia. It is important to note that the cheese servings 438 
were not consumed in one meal, instead they were spread over the three main meals, that is, 439 
70 g cheese (~5 g of extra protein per meal) consumed with breakfast, lunch and dinner. 440 
Protein intakes in Study A[47] were not reported, but if we extrapolate data from studies in 441 
similar population cohorts [52], it has been suggested that older individuals are not likely to 442 
consume an adequate amount of protein during all main meals. Tieland et al. [52] reported 443 
mean protein intakes of ~8 g, ~18 g and ~29 g for breakfast, lunch and dinner, respectively. 444 
Therefore, it is uncertain whether the addition of 5 g protein in the main meals in study A[47] 445 
was enough to significantly augment MPS.  446 
 447 
Another confounder may have been the potential impact of the addition of cheese on the 448 
habitual diet given the fact that 25 % of women in Study A[47] experienced early satiety. It 449 
could be consequently speculated that women’s habitual diet was modified with the addition 450 
of ricotta, potentially displacing the intake of other foods. However this cannot be confirmed 451 
as the habitual diet was not reported.  452 
 453 
In study A [47], even though there was a trend towards increased strength, it could be argued 454 
that higher -and perhaps different distributions of- protein intake [31] were needed to enhance 455 
muscle strength and accretion of skeletal muscle mass. It should be also noted that the power 456 
calculation for sample size was based on lean mass as the primary outcome, rather than 457 
muscle strength. Therefore, it is unknown whether a larger sample size was needed to reveal 458 
a significant change in handgrip strength. 459 
 460 
It has been previously reported that protein supplementation can enhance function in older 461 
adults. Namely, Tieland et al. [53] provided an oral supplement delivering 15 g of protein 462 
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twice daily (with breakfast and lunch) to older frail adults. This addition resulted in 463 
significantly enhanced physical performance. The potential for high protein meals to maintain 464 
or increase muscle mass and strength in older adults has been recently reported by Loenneke 465 
et al. [54] who showed that one or two meals containing 30-45 g protein · day-1 were 466 
associated with higher lean mass and strength compared with those who did not consume any 467 
meals over the threshold of 30g protein. 468 
 469 
4.2 Effects of exercise training on body composition and function in sarcopenic obesity 470 
 471 
The mechanisms underpinning the effects of exercise on body composition and function in 472 
older age are mainly accounted for by regulation of genes, circulating hormone levels (e.g. 473 
testosterone, IGF-1) and metabolic pathways (especially by activating the mechanistic target 474 
of rapamycin (mTOR), which is a pathway also activated by leucine-rich protein meals [31]) 475 
and have been reviewed in detail by Garatachea et al. [55] and McGlory and Phillips [56]. 476 
However, it is still unclear whether the modulation of these pathways can translate into real-477 
world benefits for adults with SO.  478 
 479 
In study B[48], the aim was to assess the effect of high-speed resistance exercise training on 480 
indices of SO. In spite of possible methodological limitations, the improvements in strength, 481 
power and IADL reported in study B[42], provide some evidence that exercise can improve 482 
several domains of physical performance such as strength and power in  older adults with SO. 483 
This is in agreement with previous reports supporting the benefits of resistance exercise 484 
training on clinically important outcomes, even in the absence of increased muscle mass 485 
[8][31][57]. This may be partly accounted for by the adaptive plasticity in the neuromuscular 486 
system and skeletal muscle tissue in response to resistance exercise even in advanced older 487 
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age [58]. A significant improvement particularly in power can be very important for 488 
individuals with SO since muscle power can be a predictor of mobility skills and a more 489 
influential indicator of physical capacity compared with absolute changes in strength [59]. 490 
Another interesting finding from study B[48] was the large effect size observed in peak leg 491 
power achieved by exercising at 50 % 1RM. To a certain extent, this finding may be 492 
explained by the novel aspect of the study design, that is, the resistance exercise progression 493 
protocol. Resistance load would increase only when a power plateau was reached [48]. 494 
Therefore, the protocol was designed in such a way as to favor maximum power output. 495 
 496 
The lack of significant changes in lean mass or muscle mass after exercise training in adults 497 
with sarcopenia, (which has also been reported elsewhere [8]), may be accounted for by 498 
protocol-specific differences such as: duration, type, intensity, volume and frequency of 499 
exercise, as well as the availability of adequate nutrients (protein/amino acids), which are 500 
needed to elicit an anabolic response and consequently muscle hypertrophy [31]. One 501 
limitation of study B[48] was the lack of control for dietary intake, which could have partly 502 
explained the lack of effect on body composition. It has been shown that a bout of resistance 503 
exercise can stimulate muscle protein synthesis (MPS) to a higher degree than protein 504 
breakdown, however, in the absence of post-workout provision of nutrients (especially 505 
protein) it can result in negative net muscle protein balance [60][61], and is a limitation of 506 
study designs to date.  507 
 508 
These data support the potential benefit of a resistance exercise program within lifestyle 509 
intervention protocols due to its positive effect on muscle strength, power and function in 510 
older adults with SO. Although no statistically significant body-composition changes were 511 
reported in the included studies, the significant improvements in strength, power and function 512 
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may be more important for the quality of life of adults with SO than absolute changes in body 513 
fat or lean mass per se.  514 
 515 
4.3 Recommendations for future research  516 
 517 
More intervention trials should be undertaken to identify effective lifestyle strategies in adults 518 
with SO, that will inform more robust approaches to combat this condition. Future research 519 
should also bridge the gap in knowledge with respect to multimodal approaches combining 520 
resistance exercise training with dietary strategies modulating protein intakes, in order to 521 
augment muscle mass and strength [32] or fat free mass [62], and potentially alongside an 522 
energy-deficit diet to promote fat loss [33].  523 
 524 
It is important to note that although the need to augment muscle mass is paramount, a 525 
reduction in fat mass and especially fat infiltrating the muscle tissue is equally important, 526 
since intermuscular fat can result in mobility limitations [16]. Exercise training can 527 
preferentially reduce intermuscular adipose tissue more effectively than caloric-restriction 528 
alone [63]. However, a combination of exercise with caloric-restriction can lead to greater 529 
losses of total fat mass, which in turn may result in greater improvements in physical 530 
function, sometimes even at the expense of lean tissue [64][65]. Nevertheless, it is currently 531 
unknown whether this loss of lean mass may be detrimental in the long term for the life 532 
quality of an older individual with sarcopenia who has already experienced a large decline in 533 
muscle mass and strength. 534 
 535 
To our knowledge only three studies to date, have reported significantly increased muscle or 536 
lean mass while concomitantly reducing fat mass [66-68]. The pilot study conducted by 537 
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Maltais et al. [68] was the only one that recruited older overweight adults with a low 538 
appendicular lean mass index. The authors concluded that 16-weeks of a whole body 539 
resistance exercise regimen (at 80% 1RM) followed by the consumption of ~13 g dairy 540 
supplement (chocolate milk with added milk powder) increased lean mass and reduced fat 541 
mass even at the absence of caloric restriction (n=8). In the same study, the group  that 542 
received a soy-based beverage (matched for energy, protein, essential amino acids, 543 
carbohydrate and calcium content) (n=8), reported significant increases only in lean mass but 544 
no changes in fat mass. Similar results, but in pre-menopausal women, have been reported by 545 
Josse et al. [66]. After 16 weeks of mixed exercise training (aerobic and resistance) combined 546 
with a caloric restriction (500 kcal daily deficit), only the high protein group (30% of total 547 
energy intake came from protein, half of which was derived from dairy products) experienced 548 
lean gains concomitant with fat losses. Albeit in younger adults, a recent four-week 549 
intervention combining 2.4 g protein · kg bw-1 · day-1  (achieved by consuming 3-4 whey-550 
based protein beverages daily) with a mixed resistance, plyometric and high-intensity interval 551 
training alongside an energy deficit regimen resulted in significantly higher lean mass and 552 
lower body fat [67]. The control group which differed only in protein intake (1.2 g protein · 553 
kg bw-1 · day-1) did not experience a significant change in lean mass [67].  554 
 555 
Although the effectiveness of the aforementioned paradigms needs to be evaluated in older 556 
adults with SO, they provide the framework for an initial approach to combat this condition. 557 
What is primarily lacking from the literature is trials recruiting older adults with SO. 558 
Additionally, protocols combining a high protein diet (potentially using whey or dairy 559 
proteins) with a modest caloric deficit along with a well structured exercise training regimen 560 
could be adopted. Moreover, long-term and follow-up studies with adults with SO who have 561 
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intentionally lost weight should be undertaken, in order to assess the impact of weight loss 562 
(especially if it comes from lean tissue) on life quality and other comorbidities.    563 
 564 
4.4 Limitations  565 
 566 
The main limitation of this review is the scarcity of data and studies undertaken in older 567 
groups with SO. We reviewed only studies with participants presenting the sarcopenic 568 
phenotype, as defined by the EWGSOP [1], using an appropriate methodology to assess body 569 
composition. Although the EWGSOP reached a consensus in 2010 on the definition and 570 
assessment of sarcopenia, adopting criteria for low muscle and low strength or function, there 571 
are recent studies [68][69] that use solely the criterion of low muscle mass to define 572 
sarcopenia as it was initially proposed [70], without taking into consideration low strength or 573 
function. In addition, one study conducted before 2010 was excluded because muscle mass 574 
was assessed using urinary creatinine [71], a method not included in the EWGSOP definition. 575 
Regarding the two studies included in this review, study B[48] aimed to recruit specifically 576 
participants with sarcopenic obesity. Study A[47] used sarcopenia as an inclusion criterion, 577 
and although the mean % BF values met our cut-off criteria for obesity, after personal 578 
communication with the authors it was reported that although the majority of participants had 579 
the sarcopenic obesity phenotype, a small proportion (5 out of 40) had a % BF below our cut-580 
off.  581 
Although of vital importance, there is an apparent lack of interventions with older adults with 582 
SO. This is in accordance with Finger et al. [62] who commented that interventions may refer 583 
to or discuss sarcopenia, however, the number of studies recruiting adults specifically with 584 
sarcopenia is very limited. This is even more complex with respect to studies on sarcopenic 585 
obesity, with a number of reviews [26][36][33][72] presenting interventions with participants 586 
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who either had none or only one of the conditions (sarcopenia or overweight/obesity but not 587 
both) and extrapolate these results to propose ways to improve the sarcopenic obesity 588 
phenotype.  An example of an intervention study is that by Gadelha et al. [73] investigating 589 
the effect of exercise training on changes in the sarcopenic obesity index (assessed by the 590 
residuals method initially presented by Newman et al. [40] and adopted by the EWGSOP) of 591 
older Brazilian women. However, older age was the main inclusion criterion and no criteria 592 
specific for sarcopenia or obesity were adopted.  593 
 594 
4.5 Conclusion  595 
 596 
This review assessed studies investigating the effectiveness of exercise or nutritional 597 
interventions to improve the body composition and strength/function of older adults with 598 
sarcopenia and obesity. None of the included studies significantly reduced body fat or 599 
increased either skeletal muscle mass or lean mass. Although the number of included studies 600 
was low, it is evident that exercise training can elicit significant improvements in aspects of 601 
physical fitness such as muscle strength and power, and consequently improve performance 602 
in activities of daily living in adults with SO. The addition of 15 g protein·day-1 to the 603 
habitual diet via cheese consumption revealed a non-statistically significant trend towards 604 
increased handgrip strength, and a significantly better insulin response in men, but not in 605 
women. The lack of published data highlights the necessity for new research adopting 606 
universally accepted cut-offs for sarcopenic obesity, with the inclusion of appropriately 607 
designed exercise programs and dietary regimens, and with detailed assessments of dietary 608 
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Figure 1. Relationship between sarcopenia and obesity and associated risks as well as 883 
management strategies. Notes: Solid arrow: direct and positive association; Dashed line 884 








Table 2. Summary key points of the included study designs. 889 
Study  Summary Strengths Limitations 
Study A  
Aleman-





o 40 participants  
o 3 months 
o Habitual diet plus 






o Intention to treat 
analysis 
o Body composition 





o Baseline and follow 
up clinical tests for 
kidney and liver 
function 
o Blinded personnel 
delivering the 
assessment tests.  
o Lack of baseline 
and follow up 





Study B  
Balachandran 




o 21 participants  
o 15 weeks 
o High speed circuit 





training (control)   
o Independent living 
community-
dwellers.  
o Participants were 
partially blinded to 
the intervention. 
o Testing personnel 
blinded 
o All sessions 
supervised by 2 
physiology majors 





o Characteristics of 
participants lost to 
follow-up not 
described 
o No description of 
the exercise setting 
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Table 2. Summary of the included studies 890 
Study Setting/ Study 
Design/ 
Duration 
Group Participants Mean Age  
(SD)/ characteristics 




Assessment of  
a)body composition 
b) strength or 
function 









et al. [47])   
Mexico/ RCT: 
two arms, one 
control, one 
intervention / 3 
months 
Control  76.7 (5.8) / physically-
independent, sarcopenic 
based on low TASM and 
strength, obese based on 
%BF 








DO n= 3 
F n=12 b) HG strength 
N/A 
  Intervention 75.4 (5.0)/ independent 
living sarcopenic based on 
low TASM and strength, 
obese based on %BF 
No HD plus 210 g of 
ricotta cheese/day, 












et al. [48]) 





Control 71 (8.2)/ independent 
living community dwellers 
from South Miami, 
sarcopenic based on SMI 
and strength, obese based 
on %BF and BMI 
Strength-hypertrophy 
(SH) training, 11 
exercises, 3 sets of 10-














DO n= 1 
F n=8 b) HG  strength, 
SPPB, Leg press 
1RM, Chest press 
1RM, Leg press 
power, Chest press 
power, 
85% 
  Intervention 71.6 (7.8)/ independent 
living community dwellers 
from South Miami 
High speed circuit 
(HSC) training, 11 
exercises:  3 circuits of 
10-12 reps per exercise 
at loads that 




Final n= 8 






DO n= 3 




Notes: → no significant change, ↑significant increase, ↓significant decrease, *<0.05, **<0.01, ǂ significantly better than the control group;  891 
%BF, percent body fat; BMI, body mass index; DXA, dual-energy xray absorptiometry; FM, fat mass; HG, handgrip; LM, lean mass; RCT, randomised control Trial; RM, 892 
repetition maximum; SPPB, short physical performance battery test; TASM, total appendicular skeletal muscle. 893 
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